DHDermatological Health3083-47752981-8206Bio-Byword Scientific Publishing Pty. Ltd.10.26689/dh.v2i4.9039ArticleRole of MAPK and JNK Signaling Pathways in Skin Cancer Progression and Therapeutic Approachhttps://artdesignp.com/journal/DH/2/4/10.26689/dh.v2i4.9039KhaliqHamza2025242025-01-07Mitogen-activated protein kinase (MAPK) and c-Jun N-terminal kinase (JNK) pathways exhibit complex signal transduction pathways that modulate multiple processes and the deregulated form of MAPK is involved in many types of cancers including skin cancer. These signaling pathways regulate cellular processes such as differentiation, inflammation, cell proliferation, and survival. Moreover, MAPKs are crucial signaling pathways in regulating various cellular processes, including cell proliferation, differentiation, survival, and apoptosis. Their dysregulation is commonly observed in cancer, making them attractive targets for therapeutic intervention. The critical mechanisms and pathways of MAPKs and JNKs in skin cancer including basal cell carcinoma (BCC), squamous cell carcinoma (SCC), and melanoma are summarized in this review. In addition to providing new insights into MAPK and JNK pathways in cancer progression and proliferation, we also offered the significance of the mechanism of JNK in drug resistance and the association of KLF4 in influencing JNKs for future endeavors to be targeted as therapeutic approaches as understanding the molecular aspects of these signaling pathways are crucial for novel therapeutic breakthroughs.

Bahar ME, Kim HJ, Kim DR, 2023, Targeting the RAS/RAF/MAPK Pathway for Cancer Therapy: From Mechanism to Clinical Studies. Signal Transduction and Targeted Therapy, 8(1): 455.

Manna M, Rengasamy B, Sinha AK, 2023, Revisiting the Role of MAPK Signaling Pathway in Plants and its Manipulation for Crop Improvement. Plant, Cell & Environment, 46(8): 2277–2295.

Moon H, Ro SW, 2021, MAPK/ERK Signaling Pathway in Hepatocellular Carcinoma. Cancers, 13(12): 3026.

Moustardas P, Aberdam D, Lagali N, 2023, MAPK Pathways in Ocular Pathophysiology: Potential Therapeutic Drugs and Challenges. Cells, 12(4): 617.

Yu J, Li X, Cao J, et al., 2023, Components of the JNK-MAPK Pathway Play Distinct Roles in Hepatocellular Carcinoma. Journal of Cancer Research and Clinical Oncology, 149(19): 17495–17509.

Pua LJW, Mai CW, Chung FFL, et al., 2022, Functional Roles of JNK and p38 MAPK Signaling in Nasopharyngeal Carcinoma. International Journal of Molecular Sciences, 23(3): 1108.

Musi CA, Agro G, Santarella F, et al., 2020, JNK3 as Therapeutic Target and Biomarker in Neurodegenerative and Neurodevelopmental Brain Diseases. Cells, 9(10): 2190.

Chen Q, Hou Y, Li D, et al., 2022, Berberine Induces Non-Small Cell Lung Cancer Apoptosis via the Activation of the ROS/ASK1/JNK Pathway. Annals of Translational Medicine, 10(8).

Saeed R, Mohammed AK, Saleh SE, et al., 2023, Dual Role of Mitogen-Activated Protein Kinase 8 Interacting Protein-1 in Inflammasome and Pancreatic Beta-Cell Function. International Journal of Molecular Sciences, 24(5): 4990.

Kciuk M, Gielecinska A, Budzinska A, et al., 2022, Metastasis and MAPK Pathways. International Journal of Molecular Sciences, 23(7): 3847.

Schneeweis C, Diersch S, Hassan Z, et al., 2023, AP1/Fra1 Confers Resistance to MAPK Cascade Inhibition in Pancreatic Cancer. Cellular and Molecular Life Sciences, 80(1): 12.

Martin-Vega A, Cobb MH, 2023, Navigating the ERK1/2 MAPK Cascade. Biomolecules 13(10): 1555.

Song D, Lian Y, Zhang L, 2023, The Potential of Activator Protein 1 (AP-1) in Cancer Targeted Therapy. Frontiers in Immunology, (14): 1224892.

Wojcik M, Zmarzly N, Derkacz A, et al., 2024, Gene Expression Profile of Mitogen-Activated Kinases and MicroRNAs Controlling their Expression in HaCaT Cell Culture Treated with Lipopolysaccharide A and Cyclosporine A. Cell Cycle, 23(3): 279–293.

Schnoegl D, Hiesinger A, Huntington ND, et al., 2023, AP-1 Transcription Factors in Cytotoxic Lymphocyte Development and Antitumor Immunity. Current Opinion in Immunology, (85): 102397.

Sun M, Cheng H, Yu T, et al., 2023, Involvement of a AS3MT/c‐Fos/p53 Signaling Axis in Arsenic‐Induced Tumor in Human Lung Cells. Environmental Toxicology, 38(3): 615–627.

Rehman B, Abubakar M, Kiani MN, et al., 2024, Analysis of Genetic Alterations in TP53 Gene in Breast Cancer. Proceedings of Anticancer Research, 8(3): 25–35.

Schubert L, Mariko ML, Clerc J, et al., 2023, MAPK Pathway Inhibitors in Thyroid Cancer: Preclinical and Clinical Data. Cancers, 15(3): 710.

Sharma D, Singh N, Srivastava S, 2024, Skin Cancer: An Insight on its Association with Aging, Pathogenesis and Treatment Strategies. Current Drug Research Reviews Formerly: Current Drug Abuse Reviews, 16(2): 134–144.

Hendrikse CSE, Theelen PMM, Van Der Ploeg P, et al., 2023, The Potential of RAS/RAF/MEK/ERK (MAPK) Signaling Pathway Inhibitors in Ovarian Cancer: A Systematic Review and Meta-Analysis. Gynecologic Oncology, (171): 83–94.

Shi A, Liu L, Li S, et al., 2024, Natural Products Targeting the MAPK-Signaling Pathway in Cancer: Overview. Journal of Cancer Research and Clinical Oncology, 150(1): 6.

Toye E, Chehrazi-Raffle A, Hwang J, et al., 2024, Targeting the Multifaceted BRAF in Cancer: New Directions. Oncotarget, (15): 486.

Qi XM, Chen, G, 2023, p38γ MAPK Inflammatory and Metabolic Signaling in Physiology and Disease. Cells, 12(13): 1674.

Huang Y, Wang G, Zhang N, et al., 2024, MAP3K4 Kinase Action and Dual Role in Cancer. Discover Oncology, (15): 99.

Zhan X, Kaoud TS, Dalby KN, et al., 2023, Arrestin‐3‐Dependent Activation of c‐Jun N‐Terminal Kinases (JNKs). Current Protocols, 3(9): e839.

Albert-Gasco H, Ros-Bernal F, Castillo-Gomez E, et al., 2020, MAPK/ERK Dysfunction in Neurodegenerative Diseases. Encyclopedia, 7(1): 1–8.

Zarrin AA, Bao K, Lupardus P, et al., 2021, Kinase Inhibition in Autoimmunity and Inflammation. Nature Reviews Drug Discovery, 20(1): 39–63.

Deng Y, Adam V, Nepovimova E, et al., 2023, c-Jun N-Terminal Kinase Signaling in Cellular Senescence. Archives of Toxicology, 97(8): 2089–2109.

Ryu M, Sung CK, Im YJ, et al., 2020, Activation of JNK and p38 in MCF-7 Cells and the In Vitro Anticancer Activity of Alnus hirsuta Extract. Molecules, 25(5): 1073.

Hammouda MB, Ford AE, Liu Y, et al., 2020, The JNK Signaling Pathway in Inflammatory Skin Disorders and cancer. Cells, 9(4): 857.

Xing Y, Liu Y, Qi Z, et al., 2021, LAGE3 Promoted Cell Proliferation, Migration, and Invasion and Inhibited Cell Apoptosis of Hepatocellular Carcinoma by Facilitating the JNK and ERK Signaling Pathway. Cellular & Molecular Biology Letters, (26): 1–16.

Liu Z, Li C, Wu G, et al., 2020, Involvement of JNK/FOXO1 Pathway in Apoptosis Induced by Severe Hypoxia in Porcine Granulosa Cells. Theriogenology, (154): 120–127.

Pan J, Liu H, Wu Q, et al., 2022, Scopoletin Protects Retinal Ganglion Cells 5 from High Glucose-Induced Injury in a Cellular Model of Diabetic Retinopathy via ROS-Dependent p38 and JNK Signaling Cascade. Central European Journal of Immunology, 47(1): 20–29.

Menaca-Guerrero L, Suarez-Causado A, Diaz-Caballero AJ, 2020, Reactive Species of Oxygen, Oxidative Stress and its Relationship with Tissular Destruction in Periodontitis. CES Odontologia, 33(2): 112–127.

Su CC, Lin JW, Chang KY, et al., 2022, Involvement of AMPKα and MAPK-ERK/-JNK Signals in Docetaxel-Induced Human Tongue Squamous Cell Carcinoma Cell Apoptosis. International Journal of Molecular Sciences, 23(22): 13857.

Zhou H, Zhao Q, Yue C, et al., 2022, Interleukin‐38 Promotes Skin Tumorigenesis in an IL‐1Rrp2‐Dependent Manner. EMBO Reports, 23(6): e53791.

Tam SY, Law HKW, 2021, JNK in Tumor microenvironment: present findings and Challenges in Clinical Translation. Cancers, 13(9): 2196.

Cheng Y, Chen J, Shi Y, et al., 2022, MAPK Signaling Pathway in Oral Squamous Cell Carcinoma: Biological Function and Targeted Therapy. Cancers, 14(19): 4625.

Okada M, Kawagoe Y, Takasugi T, et al., 2022, JNK1-Dependent Phosphorylation of GAP-43 Serine 142 is a Novel Molecular Marker for Axonal Growth. Neurochemical Research, 47(9): 2668–2682.

Zhang W, Wang C, Hu X, et al., 2022, Inhibition of LDHA Suppresses Cell Proliferation and Increases Mitochondrial Apoptosis via the JNK Signaling Pathway in Cervical Cancer Cells. Oncology Reports, 47(4): 1–11.

Xu D, Li C, Zhao M, 2022, Attenuation of UV-Induced Skin Photoaging in Rats by Walnut Protein Hydrolysates is Linked to the Modulation of MAPK/AP-1 and TGF-beta/Smad Signaling Pathways. Food & Function, 13(2): 609–623.

Wu Q, Wu W, Jacevic V, et al., 2020, Selective Inhibitors for JNK Signaling: A Potential Targeted Therapy in Cancer. Journal of Enzyme Inhibition and Medicinal Chemistry, 35(1): 574–583.

Yao F, Wang X, Cui ZK, et al., 2020, ETS2 Promotes Epithelial-to-Mesenchymal Transition in Renal Fibrosis by Targeting JUNB Transcription. Laboratory Investigation, 100(3): 438–453.

Cierpikowski P, Leszczyszyn A, Bar J, 2023, The Role of Hedgehog Signaling Pathway in Head and Neck Squamous Cell Carcinoma. Cells, 12(16): 2083.

Ma C, Hu K, Ullah I, et al., 2022, Molecular Mechanisms Involving the Sonic Hedgehog Pathway in Lung Cancer Therapy: Recent Advances. Frontiers in Oncology, (12): 729088.

Oliphant MUJ, Kong D, Zhou H, et al., 2020, Two Sides of the Same Coin: The Role of Developmental Pathways and Pluripotency Factors in Normal Mammary Stem Cells and Breast Cancer Metastasis. Journal of Mammary Gland Biology and Neoplasia, (25): 85–102.

Yang J, Wang J, Liu Y, et al., 2021, PGE2-JNK Signaling Axis Non-Canonically Promotes Gli Activation by Protecting Gli2 from Ubiquitin-Proteasomal Degradation. Cell Death & Disease, 12(7): 707.

Ullah A, Ullah N, Nawaz T, et al., 2023, Molecular Mechanisms of Sanguinarine in Cancer Prevention and Treatment. Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-Anti-Cancer Agents), 23(7): 765–778.

Bao F, Hao P, An S, et al., 2021, Akt Scaffold Proteins: The Key to Controlling Specificity of Akt Signaling. American Journal of Physiology-Cell Physiology, 321(3): C429–C442.

Garmpis N, Damaskos C, Garmpi A, et al., 2021, Histone Deacetylase Inhibitors in the Treatment of Hepatocellular Carcinoma: Current Evidence and Future Opportunities. Journal of Personalized Medicine, 11(3): 223.

Song H, Guja KE, Iagaru A, 2021, 18F-FDG PET/CT for Evaluation of Post-Transplant Lymphoproliferative Disorder (PTLD). Seminars in Nuclear Medicine, 51(4): 392–403.

Chen C, Cheng Y, Lei H, et al., 2023, SHP2 Potentiates anti-PD-1 Effectiveness through Intervening Cell Pyroptosis Resistance in Triple-Negative Breast Cancer. Biomedicine & Pharmacotherapy, (168): 115797.

Hamp I, O’Neill TJ, Plettenburg O, et al., 2021, A Patent Review of MALT1 Inhibitors (2013-present). Expert Opinion on Therapeutic Patents, 31(12): 1079–1096.

Krishnan D, Menon RN, Gopala S, 2022, SHARPIN: Role in Finding NEMO and in Amyloid-Beta Clearance and Degradation (ABCD) Pathway in Alzheimer’s Disease? Cellular and Molecular Neurobiology, 42(5): 1267–1281.

Zhong J, Yan W, Wang C, et al., 2022, BRAF Inhibitor Resistance in Melanoma: Mechanisms and Alternative Therapeutic Strategies. Current Treatment Options in Oncology, 23(11): 1503–1521.

Zhai Z, Vaddi PK, Samson JM, et al., 2020, NLRP1 Functions Downstream of the MAPK/ERK Signaling via ATF4 and Contributes to Acquired Targeted Therapy Resistance in Human Metastatic Melanoma. Pharmaceuticals, 14(1): 23.

Beretti F, Gatti M, Zavatti M, et al., 2023, Reactive Oxygen Species Regulation of Chemoresistance and Metastatic Capacity of Melanoma: Role of the Cancer Stem Cell Marker CD271. Biomedicines, 11(4): 1229.

Pawlikowska M, Piotrowski J, Jędrzejewski T, et al., 2020, Coriolus versicolor‐Derived Protein‐Bound Polysaccharides Trigger the Caspase‐Independent Cell Death Pathway in Amelanotic but not Melanotic Melanoma Cells. Phytotherapy Research, 34(1): 173–183.

Ke R, Kumar S, Singh SK, et al., 2024, Molecular Insights into the Role of Mixed Lineage Kinase 3 in Cancer Hallmarks. Biochimica et Biophysica Acta (BBA)-Reviews on Cancer, 1879(5): 189157.

Pua LJW, Mai CW, Chung FFL, et al., 2022, Functional Roles of JNK and p38 MAPK Signaling in Nasopharyngeal Carcinoma. International Journal of Molecular Sciences, 23(3): 1108.

Abdelrahman KS, Hassan HA, Abdel-Aziz SA, et al., 2021, JNK Signaling as a Target for Anticancer Therapy. Pharmacological Reports, (73): 405–434.

Chen T, Zhao L, Chen S, et al., 2020, The Curcumin Analogue WZ35 Affects Glycolysis Inhibition of Gastric Cancer Cells through ROS-YAP-JNK Pathway. Food and Chemical Toxicology, (137): 111131.

Liu L, Xing Y, Cao M, et al., 2021, Exogenous NO Induces Apoptosis of Hepatocellular Carcinoma Cells via Positive p38/JNK Signaling Pathway and Negative ERK Signaling Pathways. Molecular and Cellular Biochemistry, (476): 1651–1661.

de los Reyes Corrales T, Losada-Perez M, Casas-Tinto S, 2021, JNK Pathway in CNS Pathologies. International Journal of Molecular Sciences, 22(8): 3883.

Meng Q, Xu Y, Li Y, et al., 2023, Novel Studies on Drosophila melanogaster Model Reveal the Roles of JNK-Jak/STAT Axis and Intestinal Microbiota in Insulin Resistance. Journal of Drug Targeting, 31(3): 261–268.

Fonseca Teixeira A, Wu S, Luwor R, et al., 2023, A New Era of Integration between Multiomics and Spatio-Temporal Analysis for the Translation of EMT towards Clinical Applications in Cancer. Cells, 12(23): 2740.

Mahgoub E, Taneera J, Ahmed B, et al., 2024, Unraveling the Interplay of Autophagy Genes and KLF3/KLF8 in Colorectal Cancer Metastasis: A Bioinformatics and Cellular Exploration. F1000Research, (13): 850.

He Z, He J, Xie K, 2023, KLF4 Transcription Factor in Tumorigenesis. Cell Death Discovery, 9(1): 118.

Li Y, Li S, Shi X, et al., 2023, KLF12 Promotes the Proliferation of Breast Cancer Cells by Reducing the Transcription of p21 in a p53-Dependent and p53-Independent Manner. Cell Death & Disease, 14(5): 313.

Zheng Y, Wu J, Chen H, et al., 2023, KLF4 Targets RAB26 and Decreases 5-FU Resistance through Inhibiting Autophagy in Colon Cancer. Cancer Biology & Therapy, 24(1): 2226353.

Meyers WM, 2024, Transcriptional Regulation of the Alternative Sex Hormone-Binding Globulin Promoter by KLF4. Gene Expression Patterns, 2024: 119357.

Verstappe J, Berx G, 2023, A Role for Partial Epithelial-to-Mesenchymal Transition in Enabling Stemness in Homeostasis and Cancer. Seminars in Cancer Biology, (90): 15–28.

Li ZY, Zhu YX, Chen JR, et al., 2023, The Role of KLF Transcription Factor in the Regulation of Cancer Progression. Biomedicine & Pharmacotherapy, (162): 114661.

Avendano-Felix M, Aguilar-Medina M, Romero-Quintana JG, et al., 2023, SOX9 Knockout Decreases Stemness Properties in Colorectal Cancer Cells. Journal of Gastrointestinal Oncology, 14(4): 1735.

Den Hollander P, Maddela JJ, Mani SA, 2024, Spatial and Temporal Relationship between Epithelial-Mesenchymal Transition (EMT) and Stem Cells in Cancer. Clinical Chemistry, 70(1): 190–205.

Prajapati KS, Gupta S, Choudhari S, et al., 2024, Role of ONECUT Family Transcription Factors in Cancer and Other Diseases. Experimental Cell Research, 438(1): 114035.

Blum A, Mostow K, Jackett K, et al., 2021, KLF4 Regulates Metabolic Homeostasis in Response to Stress. Cells 2021, (10): 830.

Mavrogonatou E, Angelopoulou M, Rizou SV, et al., 2022, Activation of the JNKs/ATM-p53 Axis is Indispensable for the Cytoprotection of Dermal Fibroblasts Exposed to UVB radiation. Cell Death & Disease, 13(7): 647.

Bhosale PB, Kim HH, Abusaliya A, et al., 2022, Structural and Functional Properties of Activator Protein‐1 in Cancer and Inflammation. Evidence‐Based Complementary and Alternative Medicine, 2022(1): 9797929.

Semba T, Sammons R, Wang X, et al., 2020, JNK Signaling in Stem Cell Self-Renewal and Differentiation. International Journal of Molecular Sciences, 21(7): 2613.

Viola L, Londero AP, Bertozzi S, et al., 2020, Prognostic Role of Kruppel-Like Factors 5, 9, and 11 in Endometrial Endometrioid Cancer. Pathology & Oncology Research, (26): 2265–2272.

Waryah C, Alves E, Mazzieri R, et al., 2023, Unpacking the Complexity of Epithelial Plasticity: From Master Regulator Transcription Factors to Non-Coding RNAs. Cancers, 15(12): 3152.

Yang Z, Peng Y, Wang Y, et al., 2023, KLF5 Regulates Actin Remodeling to Enhance the Metastasis of Nasopharyngeal Carcinoma. Oncogene, 43(23): 1779–1795.